» Articles » PMID: 31848049

Computational Screening of Potential Regulators for MRNA-protein Expression Level Discrepancy

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2019 Dec 19
PMID 31848049
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Complicated post-transcriptional and translational regulation processes contribute to the expression discrepancy between mRNA and protein in many tissues, but the underlying mechanisms have not been fully understood. In this study, we assessed to what extent and which RNA binding proteins (RBPs) contribute to mRNA-protein expression discrepancy. To this end, we exploited the RNA-seq transcriptome data and corresponding quantitative proteome data from the same set of human healthy tissues to estimate the mRNA-protein expression discrepancy, and observed that a considerable fraction of genes show obvious difference in expression rankings between transcriptome and proteome. We further assembled the latest CLIP-seq datasets from POSTAR2, ENCODE and GEO to map the binding profiles of known RBPs. A logistic regression model based on the RBP-binding features was established, which could predict the mRNA-protein expression discrepancy with acceptable performance. Finally, by applying two different feature selection methods on this logistic regression model, we identified a consensus set of known and putative translation regulators which may account for the expression level discrepancy, such as G3BP1, DGCR8, LARP4B, EIF4A3 and FXR2.

Citing Articles

Ribosomal modification protein rimK-like family member A activates betaine-homocysteine S-methyltransferase 1 to ameliorate hepatic steatosis.

Yan H, Liu W, Xiang R, Li X, Hou S, Xu L Signal Transduct Target Ther. 2024; 9(1):214.

PMID: 39117631 PMC: 11310345. DOI: 10.1038/s41392-024-01914-0.


Amelioration of oxidative kidney damage in offspring by maternal trans-fatty acid exposure in mice by secoisolariciresinol diglucoside.

Chen M, Zhu R, Wu T, Zhao W Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023; 48(7):967-978.

PMID: 37724399 PMC: 10930046. DOI: 10.11817/j.issn.1672-7347.2023.220524.


RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signatures.

Packeiser E, Taher L, Kong W, Ernst M, Beck J, Hewicker-Trautwein M Cancer Cell Int. 2022; 22(1):54.

PMID: 35109825 PMC: 8812184. DOI: 10.1186/s12935-021-02422-9.


GlyinsRNA: a webserver for predicting glycosylation sites on small RNAs.

Cui C, Wu X, Zhou Y RNA Biol. 2021; 18(sup2):600-603.

PMID: 34559595 PMC: 8782180. DOI: 10.1080/15476286.2021.1982574.


Effect of eukaryotic translation initiation factor 4A3 in malignant tumors.

Zhu Y, Ren C, Yang L Oncol Lett. 2021; 21(5):358.

PMID: 33747215 PMC: 7967930. DOI: 10.3892/ol.2021.12619.